Zinger Key Points
- ImmunoPrecise announced pricing of a $1.1 million public offering.
- There's also an option for underwriters to buy an additional 165,000 shares within 30 days.
- Get access to your new suite of high-powered trading tools, including real-time stock ratings, insider trades, and government trading signals.
ImmunoPrecise Antibodies Ltd IPA shares are trading lower by 23% to $1.19 Wednesday afternoon after the company announced pricing of a $1.1 million public offering of common shares at $1.00 per share.
There's an option for underwriters to buy an additional 165,000 shares within 30 days. The offering is set to close on December 8, provided it meets standard conditions.
ImmunoPrecise plans to utilize the funds for research and development, expanding lab facilities and general corporate purposes.
See Also: Cooling Signs In US Job Market Raise Concerns Ahead of November Jobs Report
According to data from Benzinga Pro, IPA has a 52-week high of $5.90 and a 52-week low of $0.94.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
